KYNTRA BIO, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

KYNTRA BIO, INC. reported Cash And Cash Equivalents At Carrying Value of $47.87 million for the year ending 2025.

  • KYNTRA BIO, INC. showed a decrease of -5.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from KYNTRA BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), KYNTRA BIO, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 23.2%.
  • Historical annual values: Fiscal year 2025: $47.87 million | Fiscal year 2024: $50.48 million | Fiscal year 2023: $81.55 million | Fiscal year 2022: $155.70 million | Fiscal year 2021: $171.22 million | Fiscal year 2020: $678.39 million | Fiscal year 2019: $126.27 million | Fiscal year 2018: $89.26 million | Fiscal year 2017: $673.66 million | Fiscal year 2016: $173.78 million | Fiscal year 2015: $153.32 million | Fiscal year 2014: $165.46 million | Fiscal year 2013: $76.33 million | Fiscal year 2012: $38.87 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: